Complete Genomics (GNOM) tacks on another 2.2% gain premarket after surging yesterday on news...

|About: Complete Genomics, Inc. (GNOM)|By:, SA News Editor

Complete Genomics (GNOM) tacks on another 2.2% gain premarket after surging yesterday on news that the Mayo Clinic will outsource whole human genome sequencing to the company. Shares are now up 59% YTD, but still trade at only a third of their 52-week highs.